Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Ridgeback Capital

Ridgeback Capital

Ridgeback Capital is a New York based investment firm which seeks long term investments in healthcare and life sciences.

OverviewStructured DataIssuesContributorsActivity

Ridgeback Capital is a New York City, New York based investment firm. They seek investments in healthcare and life science sectors.They make long term investments in private and public companies Ridgeback Capital feels are dedicated to developing life saving and life changing therapies with which they feel patient capital is vital.

Investment

Ridgeback Capital has invested in Harpoon Therapeutics, 4D Molecular Therapeutics, Precision BioSciences, Selecta Biosciences, Adaptimmune, Bellicum Pharmaceuticals, Stem Cell Therapeutics, Microbia, Alveolus and Nested.

Ridgeback Capital has exited from investments in Precision BioSciences, Adaptimmune, Harpoon Therapeutics, Selecta Biosciences, Bellicum Pharmaceuticals, Stem Cell Therapeutics, Microbia and Alveolus.

Timeline

No Timeline data yet.

Associated Investment Funds

Accelerator Batches

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Funding Rounds Participated In

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Ridgeback Capital

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.